[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100504953":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":40,"responsibleParty":67,"collaborators":69,"id":79,"slug":18,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":18,"eligibilityCriteria":84,"healthyVolunteers":80,"sex":85,"minAge":86,"maxAge":87,"enrollmentInfo":88,"targetDuration":18,"studyType":91,"phases":92,"briefSummary":94,"conditions":95,"keywords":102,"overallStatus":43,"whyStopped":18,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Zealand University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","An invitation to a liver stiffness measurement (Transient Elastography), to blood sampling and a leaflet on alcohol-related disease.",[13],"Diagnostic Test: Transient Elastography",{"label":15,"type":16,"description":17,"interventionNames":18},"Control","NO_INTERVENTION","An invitation to screening by blood sampling with Fib-4",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","Transient Elastography","One transient elastography 1-2 weeks after randomization",[9],[26,27],"Fibroscan","Liver stiffness measurement",[29],{"name":30,"affiliation":5,"role":31},"Gro Askgaard, PHD","PRINCIPAL_INVESTIGATOR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":18,"email":37},"Pernille Dahlin, MD","CONTACT","+45 30291114","pedah@regionsjaelland.dk",{"name":30,"role":35,"phone":18,"phoneExt":18,"email":39},"gras@regionsjaelland.dk",[41,56],{"facility":42,"status":43,"city":44,"state":18,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Novavi Køge","RECRUITING","Køge","4600","Denmark",{"type":48,"coordinates":49},"Point",[50,51],12.18214,55.45802,{"lat":51,"lon":50},[54],{"name":34,"role":35,"phone":55,"phoneExt":18,"email":37},"30291114",{"facility":57,"status":43,"city":58,"state":18,"zip":59,"country":46,"cosmosGeoPoint":60,"geoPoint":64,"contacts":65},"Novavi Roskilde","Roskilde","4000",{"type":48,"coordinates":61},[62,63],12.08035,55.64152,{"lat":63,"lon":62},[66],{"name":34,"role":35,"phone":55,"phoneExt":18,"email":37},{"type":68,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[70,73,75,77],{"name":71,"class":72},"Novavi","UNKNOWN",{"name":74,"class":6},"Aarhus University Hospital",{"name":76,"class":6},"Frederiksberg University Hospital",{"name":78,"class":6},"University of Copenhagen","100504953",false,"NCT05855031","The Liver Care Trial","The Liver Care Trial: Screening for Liver Disease in Individuals Attending Treatment for Alcohol Use Disorder - a Randomized Controlled Study","Inclusion Criteria:\n\n* Attending outpatient treatment for alcohol use disorder (international classification of disease version 10: F102: alcohol dependence or F101: harmful alcohol use) at Novavi Køge or Novavi Roskilde\n* Informed written consent\n\nExclusion Criteria:\n\n* Not speaking Danish or English\n* Severe liver disease (known by the participant)","ALL","18 Years","110 Years",{"count":89,"type":90},408,"ESTIMATED","INTERVENTIONAL",[93],"NA","The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units\u002Fweek) throughout the last months, and assessed 6 months after randomization.",[96,97,98,99,100,101],"Alcoholic Liver Disease","Alcohol Use Disorder","Alcohol Abuse","Alcoholism","Fibrosis, Liver","Alcohol-Related Disorders",[103,26,27,104],"Screening","abstinence","2023-05-15",{"date":107,"type":108},"2023-05-17","ACTUAL",{"date":110,"type":108},"2023-05-08",{"date":112,"type":90},"2027-05-01",{"name":5,"class":6},2]